Induced humoral immunity and vaccination against major human fungal pathogens

Arturo Casadevall, Marta Feldmesser, Liise-anne Pirofski

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

Protection against fungal pathogens can theoretically be elicited by vaccines that stimulate humoral or cellular immunity, or both. There is conclusive evidence that humoral immunity can modify the course of infection against certain pathogenic fungi such as Candida albicans and Cryptococcus neoformans. However, for other fungi, such as Aspergillus fumigatus, the notion that humoral immunity contributes to host defence is unproven. Attempts to evaluate the potential efficacy of humoral immunity using immune sera are often inconclusive, whereas consistent results can be obtained with monoclonal antibodies. Protective monoclonal antibodies can be used to identify antigens that induce useful humoral responses.

Original languageEnglish (US)
Pages (from-to)386-391
Number of pages6
JournalCurrent Opinion in Microbiology
Volume5
Issue number4
DOIs
StatePublished - 2002

Fingerprint

Humoral Immunity
Vaccination
Fungi
Monoclonal Antibodies
Cryptococcus neoformans
Aspergillus fumigatus
Candida albicans
Cellular Immunity
Immune Sera
Vaccines
Antigens
Infection

ASJC Scopus subject areas

  • Infectious Diseases
  • Microbiology

Cite this

Induced humoral immunity and vaccination against major human fungal pathogens. / Casadevall, Arturo; Feldmesser, Marta; Pirofski, Liise-anne.

In: Current Opinion in Microbiology, Vol. 5, No. 4, 2002, p. 386-391.

Research output: Contribution to journalArticle

@article{294cbdc1ce2d402888776917c13747d5,
title = "Induced humoral immunity and vaccination against major human fungal pathogens",
abstract = "Protection against fungal pathogens can theoretically be elicited by vaccines that stimulate humoral or cellular immunity, or both. There is conclusive evidence that humoral immunity can modify the course of infection against certain pathogenic fungi such as Candida albicans and Cryptococcus neoformans. However, for other fungi, such as Aspergillus fumigatus, the notion that humoral immunity contributes to host defence is unproven. Attempts to evaluate the potential efficacy of humoral immunity using immune sera are often inconclusive, whereas consistent results can be obtained with monoclonal antibodies. Protective monoclonal antibodies can be used to identify antigens that induce useful humoral responses.",
author = "Arturo Casadevall and Marta Feldmesser and Liise-anne Pirofski",
year = "2002",
doi = "10.1016/S1369-5274(02)00337-5",
language = "English (US)",
volume = "5",
pages = "386--391",
journal = "Current Opinion in Microbiology",
issn = "1369-5274",
publisher = "Elsevier Limited",
number = "4",

}

TY - JOUR

T1 - Induced humoral immunity and vaccination against major human fungal pathogens

AU - Casadevall, Arturo

AU - Feldmesser, Marta

AU - Pirofski, Liise-anne

PY - 2002

Y1 - 2002

N2 - Protection against fungal pathogens can theoretically be elicited by vaccines that stimulate humoral or cellular immunity, or both. There is conclusive evidence that humoral immunity can modify the course of infection against certain pathogenic fungi such as Candida albicans and Cryptococcus neoformans. However, for other fungi, such as Aspergillus fumigatus, the notion that humoral immunity contributes to host defence is unproven. Attempts to evaluate the potential efficacy of humoral immunity using immune sera are often inconclusive, whereas consistent results can be obtained with monoclonal antibodies. Protective monoclonal antibodies can be used to identify antigens that induce useful humoral responses.

AB - Protection against fungal pathogens can theoretically be elicited by vaccines that stimulate humoral or cellular immunity, or both. There is conclusive evidence that humoral immunity can modify the course of infection against certain pathogenic fungi such as Candida albicans and Cryptococcus neoformans. However, for other fungi, such as Aspergillus fumigatus, the notion that humoral immunity contributes to host defence is unproven. Attempts to evaluate the potential efficacy of humoral immunity using immune sera are often inconclusive, whereas consistent results can be obtained with monoclonal antibodies. Protective monoclonal antibodies can be used to identify antigens that induce useful humoral responses.

UR - http://www.scopus.com/inward/record.url?scp=0036345760&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036345760&partnerID=8YFLogxK

U2 - 10.1016/S1369-5274(02)00337-5

DO - 10.1016/S1369-5274(02)00337-5

M3 - Article

C2 - 12160857

AN - SCOPUS:0036345760

VL - 5

SP - 386

EP - 391

JO - Current Opinion in Microbiology

JF - Current Opinion in Microbiology

SN - 1369-5274

IS - 4

ER -